Depressive Disorder: all 4,847 studies

Page 13 of 49. Open to participants first (509), then studies with results posted, then the rest; newest registration first within each.

• A Safety Study in Participants With Major Depressive DisorderCompletedNCT01155661Phase 3Results posted
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderCompletedNCT01153347Phase 3Results posted
• Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT01153009Phase 3Results posted
• Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension StudyCompletedNCT01152996Phase 3Results posted
• A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderCompletedNCT01152554Phase 3Results posted
• Measuring Quality of Decisions About Treatment of DepressionCompletedNCT01152307Not applicableResults posted
• Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.CompletedNCT01148979Phase 4Results posted
• 6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive DisorderTerminatedNCT01145755Phase 2Results posted
• Hepatitis C Translating Initiatives for Depression Into Effective SolutionsCompletedNCT01143896Not applicableResults posted
• Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in AdultsCompletedNCT01140906Phase 3Results posted
• A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)CompletedNCT01138007Phase 3Results posted
• Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic RegulationCompletedNCT01134731Phase 4Results posted
• Acute Psychotherapy for Bipolar II DepressionCompletedNCT01133821Phase 4Results posted
• ADAPT: Addressing Depression and Pain TogetherCompletedNCT01124188Phase 4Results posted
• To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01123707Phase 3Results posted
• Project SERVE: Post Deployment FunctioningCompletedNCT01123642Results posted
• Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderTerminatedNCT01121536Phase 3Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)CompletedNCT01121484Phase 4Results posted
• Duloxetine for Menopausal DepressionCompletedNCT01117857Phase 4Results posted
• Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as Adjuvant Treatment for DepressionTerminatedNCT01115699Not applicableResults posted
• Motivational Interviews for Depression in Primary CareCompletedNCT01114334Not applicableResults posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111565Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111552Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111539Phase 3Results posted
• Pilot Study of Open-label Placebo to Treat Major Depressive DisorderCompletedNCT01103271Phase 2Results posted
• Rhodiola Rosea Therapy of Major Depressive DisorderCompletedNCT01098318Phase 3Results posted
• Integrating Depression Services Into DM ManagementCompletedNCT01098253Not applicableResults posted
• A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major DepressionTerminatedNCT01098240Phase 2Results posted
• Depression Attention for Women Now (The DAWN Study)CompletedNCT01096316Not applicableResults posted
• Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive DisorderCompletedNCT01085812Phase 3Results posted
• Text Messaging and Cognitive Behavioral Therapy for DepressionCompletedNCT01083628Not applicableResults posted
• Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With DepressionCompletedNCT01078298Phase 4Results posted
• Carcinogenicity Study of BupropionCompletedNCT01077596Results posted
• A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCompletedNCT01072929Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCompletedNCT01072630Phase 3Results posted
• Buprenorphine for Late-Life Treatment Resistant DepressionCompletedNCT01071538Phase 2Results posted
• A Study in Depression and Associated Painful Physical SymptomsCompletedNCT01070329Phase 4Results posted
• Nonconvulsive Electrotherapy: a Proof-of-concept TrialCompletedNCT01065597Phase 1Results posted
• Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)CompletedNCT01056289Phase 4Results posted
• A Study of the Neurobiology of DepressionCompletedNCT01051466Phase 4Results posted
• Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar DepressionTerminatedNCT01051440Phase 4Results posted
• Bipolar Depression Before and After Lamotrigine TreatmentCompletedNCT01042496Phase 3Results posted
• Mindfulness Based Cognitive Therapy for Recurrent DepressionCompletedNCT01038765Not applicableResults posted
• Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort SyndromeCompletedNCT01035073Phase 4Results posted
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive DisorderCompletedNCT01034462Phase 3Results posted
• Comparison of Depression Interventions After Acute Coronary SyndromeCompletedNCT01032018Phase 1/2Results posted
• PET Biomarkers in Treatment Resistant DepressionTerminatedNCT01031810Phase 4Results posted
• fMRI Study of Treatment Changes in Major DepressionCompletedNCT01027559Not applicableResults posted
• AZD7268 Safety and Tolerability StudyCompletedNCT01020799Phase 2Results posted
• Evaluation of a Diabetes-specific Cognitive Behavioural Treatment for Subthreshold DepressionCompletedNCT01009138Not applicableResults posted
• Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective AnalysisCompletedNCT01001559Results posted
• A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful SymptomsCompletedNCT01000805Phase 4Results posted
• Treatment of Depression in Acute Coronary Syndrome (ACS) PatientsCompletedNCT00998400Not applicableResults posted
• This is a Study to Determine the Antidepressant Effects of AZD6765CompletedNCT00986479Phase 2Results posted
• SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive DisorderCompletedNCT00985725Phase 2Results posted
• E-Mental Health Adolescent Depression Program (LEAP)CompletedNCT00985686Not applicableResults posted
• A Study of Patients With Major Depressive Disorder and Residual ApathyCompletedNCT00985504Phase 4Results posted
• Brain Imaging of Quetiapine Response in Anxious DepressionCompletedNCT00982345Phase 4Results posted
• Clinical Study to Test a New Drug to Treat Major DepressionCompletedNCT00976560Phase 2Results posted
• The Effect on Depressive Symptoms in ECF Residents With COPDCompletedNCT00974246Phase 4Results posted
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive DisorderCompletedNCT00969709Phase 3Results posted
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive DisorderCompletedNCT00969150Phase 3Results posted
• Escitalopram (Lexapro) for Depression MS or ALSCompletedNCT00965497Phase 3Results posted
• The Role Of Omega-3 Fatty Acids In Adolescent DepressionCompletedNCT00962598Phase 2Results posted
• The Effect of Exercise on Preventing PostPartum DepressionCompletedNCT00961402Phase 2Results posted
• A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive DisorderCompletedNCT00960986Phase 4Results posted
• A Study in Relapse Prevention of Treatment-Resistant DepressionCompletedNCT00958568Phase 3Results posted
• Study of 6(S)-5-MTHF Among Selective Serotonin Reuptake Inhibitor-Resistant Outpatients With Major Depressive DisorderCompletedNCT00955955Phase 4Results posted
• Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic SymptomsTerminatedNCT00955474Phase 4Results posted
• Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant DepressionCompletedNCT00953745Not applicableResults posted
• Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of MidazolamCompletedNCT00952653Phase 4Results posted
• Cardiovascular Biomarkers and Quetiapine in Depression and Anxiety PatientsCompletedNCT00951483Phase 4Results posted
• Chronic Kidney Disease Antidepressant Sertraline TrialCompletedNCT00946998Phase 3Results posted
• Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring AnxietyCompletedNCT00930293Not applicableResults posted
• Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar DepressionCompletedNCT00926393Phase 4Results posted
• Using a Text-message System to Engage Depressed Adolescents in Cognitive-behavioral Therapy HomeworkCompletedNCT00919932Not applicableResults posted
• Aging Brain Changes, Executive Dysfunction and DepressionCompletedNCT00918684Phase 4Results posted
• Using Affective Differences to Predict Response to Behavioral Treatment for Major Depressive DisorderCompletedNCT00909220Results posted
• Brain Imaging Techniques That Predict Antidepressant ResponsivenessCompletedNCT00909155Not applicableResults posted
• Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an AntidepressantCompletedNCT00905424Phase 2Results posted
• Preventing Depression in the Children of Depressed African American MothersCompletedNCT00904917Phase 1Results posted
• Functional MRI Before and After Treatment for DepressionTerminatedNCT00896441Not applicableResults posted
• Safety and Efficacy Study in Patients With Major Depressive DisorderCompletedNCT00896363Phase 2Results posted
• Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY)CompletedNCT00892047Phase 4Results posted
• Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive DisorderCompletedNCT00887224Phase 3Results posted
• Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT00882362Phase 3Results posted
• A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive DisorderTerminatedNCT00880399Phase 2Results posted
• A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive DisorderTerminatedNCT00880048Phase 2Results posted
• Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT00876343Phase 3Results posted
• Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care UnitCompletedNCT00872027Phase 4Results posted
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I DepressionCompletedNCT00868959Phase 3Results posted
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)CompletedNCT00868699Phase 3Results posted
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)CompletedNCT00868452Phase 3Results posted
• Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety DisorderTerminatedNCT00868374Phase 3Results posted
• Treatment of Psychotic Major Depression With MifepristoneTerminatedNCT00867360Phase 3Results posted
• Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)CompletedNCT00866294Phase 3Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive DisorderCompletedNCT00863798Phase 3Results posted
• Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on TherapyCompletedNCT00857584Phase 3Results posted
• Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive DisorderCompletedNCT00854100Phase 2Results posted
• Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar DepressionCompletedNCT00852202Phase 2Results posted

← Depressive Disorder overview